Searched for
LUPIN LATEST
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Mutual funds cut technology sector exposure to 8-year low in April. Is AI disruption reshaping sentiment?Mutual funds have significantly reduced their technology sector exposure to an eight-year low, driven by concerns over AI disruption, slowi...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Lupin clears Mirabegron patent dispute with Astellas in $90 million deal, secures US sales continuityDrugmaker Lupin has settled a patent infringement dispute with Astellas Pharma over its Mirabegron product for $90 million. The agreement i...
- Lupin divests women's health specialty business in US to Evofem Biosciences for nearly $84 mnLupin announced the sale of its US commercial women’s health specialty business, focusing on Solosec, to Evofem Biosciences. Solosec, an FD...
- Lupin enters CDMO business, names Abdelaziz Toumi as CEO of new subsidiaryLupin, a pharmaceutical company, has launched a new subsidiary named Lupin Manufacturing Solutions (LMS) to enter the Contract Development ...
- Lupin acquires two diabetes brands from Boehringer IngelheimLupin has been marketing Ondero and Ondero Met since 2015 in the Indian market as part of a co-marketing agreement with Boehringer Ingelhei...
- Buy Lupin, target price Rs 1100: Emkay GlobalLupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 33653.72 Crore) operating in Pharmaceuticals s...
- Buy Lupin, target price Rs 1150: Emkay GlobalLupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 40422.33 Crore) operating in Pharmaceuticals s...
- Lupin launches educational website Sciflix for medical studentsSciflix is a comprehensive learning platform in pulmonology where all scientific needs of postgraduate students will be addressed by a mult...
- Lupin launches digital asthma educator platformThe new platform is the latest initiative under Lupin's long running umbrella programme, Joint Airways Initiative (JAI), for patients suffe...
- Buy Lupin, price target Rs 580: Shrikant ChouhanThe analyst suggested a stoploss at Rs 540 .
- Lupin gets 2 observations from USFDA for Nagpur facility"The inspection closed with two 483 observations," Lupin said.
- Lupin recalls over 23,000 bottles of antibiotic drug in USDrug major Lupin is recalling over 23,000 bottles of an antibiotic drug in the US for being sub-potent, US Food and Drug Administration (US...
- Lupin's US arm recalls 12,888 bottles of ulcer drug in USThe reason for the recall is current Good Manufacturing Practise (CGMP) deviations, United States Food and Drug Administration (USFDA) said...
- Lupin recalls 12,480 bottles of anti-depressant drug from USLupin Pharmaceuticals Inc is recalling 12,480 bottles of Paroxetine extended-release tablets in the strength of 12.5 mg manufactured by Lup...
- Lupin launches Methergine brand in US; drugmaker markets five brands in this marketLupin is bolstering its US branded drugs portfolio with the introduction of Methergine, an oral tablet used to treat postpartum haemorrhage...
- Lupin get the DCGI nod for IVABRADPharmaceutical firm Lupin said it has received the nod of Drug Controller General of India (DCGI) for IVABRAD tablets, used in the treatmen...
Load More
